Laakkonen P - Search Results

1

A tumor-homing peptide with a targeting specificity related to lymphatic vessels.

Laakkonen P, Porkka K, Hoffman JA, Ruoslahti E. Laakkonen P, et al. Nat Med. 2002 Jul;8(7):751-5. doi: 10.1038/nm720. Epub 2002 Jun 10. Nat Med. 2002. PMID: 12053175

2

Solution structures and integrin binding activities of an RGD peptide with two isomers.

Assa-Munt N, Jia X, Laakkonen P, Ruoslahti E. Assa-Munt N, et al. Among authors: laakkonen p. Biochemistry. 2001 Feb 27;40(8):2373-8. doi: 10.1021/bi002101f. Biochemistry. 2001. PMID: 11327857

3

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo.

Porkka K, Laakkonen P, Hoffman JA, Bernasconi M, Ruoslahti E. Porkka K, et al. Among authors: laakkonen p. Proc Natl Acad Sci U S A. 2002 May 28;99(11):7444-9. doi: 10.1073/pnas.062189599. Proc Natl Acad Sci U S A. 2002. PMID: 12032302 Free PMC article.

4

Nanocrystal targeting in vivo.

Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Akerman ME, et al. Among authors: laakkonen p. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12617-21. doi: 10.1073/pnas.152463399. Epub 2002 Sep 16. Proc Natl Acad Sci U S A. 2002. PMID: 12235356 Free PMC article.

5

[Ligandomics--a tool for the development of targeted treatments].

Porkka K, Laakkonen P. Porkka K, et al. Among authors: laakkonen p. Duodecim. 2002;118(11):1185-92. Duodecim. 2002. PMID: 12239852 Review. Finnish. No abstract available.

6

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.

Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Christian S, et al. Among authors: laakkonen p. J Cell Biol. 2003 Nov 24;163(4):871-8. doi: 10.1083/jcb.200304132. J Cell Biol. 2003. PMID: 14638862 Free PMC article.

7

Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.

Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D. Joyce JA, et al. Among authors: laakkonen p. Cancer Cell. 2003 Nov;4(5):393-403. doi: 10.1016/s1535-6108(03)00271-x. Cancer Cell. 2003. PMID: 14667506 Free article.

8

Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.

Laakkonen P, Akerman ME, Biliran H, Yang M, Ferrer F, Karpanen T, Hoffman RM, Ruoslahti E. Laakkonen P, et al. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6. doi: 10.1073/pnas.0403317101. Epub 2004 Jun 14. Proc Natl Acad Sci U S A. 2004. PMID: 15197262 Free PMC article.

9

Peptide targeting of tumor lymph vessels.

Laakkonen P, Zhang L, Ruoslahti E. Laakkonen P, et al. Ann N Y Acad Sci. 2008;1131:37-43. doi: 10.1196/annals.1413.003. Ann N Y Acad Sci. 2008. PMID: 18519957 Review.

10

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.

Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Waltari M, Hellström M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylä-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K. Tammela T, et al. Among authors: laakkonen p. Nature. 2008 Jul 31;454(7204):656-60. doi: 10.1038/nature07083. Epub 2008 Jun 25. Nature. 2008. PMID: 18594512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page